Leslie Wilder

Leslie Wilder, Vice President, Head of Regulatory Science, joined bluebird bio in 2018 as lead of the Regulatory Science CMC team. In 2022, she stepped in to lead the Regulatory Science organization with a focus on bringing treatment options to severe genetic patients and their families.

Prior to joining bluebird, Leslie held regulatory positions at Alexion, Synageva, and Genzyme. While at Genzyme, Leslie was a founding member of the Molecule Steward Team, where she provided technical oversight for post-approval lifecycle management of an enzyme replacement protein, an experience that she considers her MSAT sabbatical. Leslie is a graduate of Union College, from which she holds BS, MS degrees in Biology with extensive coursework in Chemistry.